This inventor holds 1 USPTO granted patent. Top assignee: Baylor Research Institute. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Treatment by Inventor Wenhao Weng
Introduction
Wenhao Weng is a notable inventor based in Dallas, TX (US), recognized for his contributions to cancer research and treatment. His innovative work focuses on improving methods for diagnosing, prognosing, and treating colorectal cancer through biomarker expression.
Latest Patents
Weng holds a patent titled "Methods for diagnosing, prognosing, and treating colorectal cancer using biomarker expression." This patent addresses the dysregulated expression of microRNAs (miRNAs), which has become a significant feature in human cancers. The methods disclosed in this patent aim to select optimal therapy for patients from various treatment options. A major challenge in cancer treatment is identifying which patients will benefit from specific therapeutic regimens, especially in metastatic and adjuvant settings. Despite the increase in anti-cancer drugs and multi-drug combinations over the past decade, treatments are often applied empirically. Weng's methods and compositions provide a framework for determining the best treatment options for cancer patients.
Career Highlights
Wenhao Weng is affiliated with the Baylor Research Institute, where he continues to advance his research in cancer treatment. His work is pivotal in bridging the gap between empirical treatment approaches and personalized medicine.
Collaborations
Weng collaborates with esteemed colleagues, including Ajay Goel and Raju Kandimalla, who contribute to the research and development of innovative cancer therapies.
Conclusion
Wenhao Weng's innovative approaches to cancer treatment exemplify the potential of personalized medicine in improving patient outcomes. His contributions are vital in the ongoing battle against colorectal cancer, showcasing the importance of research and innovation in healthcare.